Showing 1 - 10 of 2,661
We analyze the financial performance of a hypothetical portfolio of 120 mRNA vaccine candidates in the preclinical stage targeting 11 emerging infectious diseases. We calibrate the simulation parameters with input from domain experts in mRNA technology and an extensive literature review. We find...
Persistent link: https://www.econbiz.de/10013334345
Persistent link: https://www.econbiz.de/10000146735
Persistent link: https://www.econbiz.de/10000122474
Persistent link: https://www.econbiz.de/10000136566
Persistent link: https://www.econbiz.de/10000138696
Persistent link: https://www.econbiz.de/10000168055
Persistent link: https://www.econbiz.de/10000168120
Persistent link: https://www.econbiz.de/10000168224
Persistent link: https://www.econbiz.de/10000898023